Establishment Labs Holdings Inc. (NASDAQ:ESTA) is Union Square Park Capital Management LLC's 6th Largest Position

Union Square Park Capital Management LLC lifted its holdings in shares of Establishment Labs Holdings Inc. (NASDAQ:ESTA - Free Report) by 47.0% in the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 160,000 shares of the company's stock after purchasing an additional 51,192 shares during the quarter. Establishment Labs comprises approximately 4.8% of Union Square Park Capital Management LLC's investment portfolio, making the stock its 6th biggest position. Union Square Park Capital Management LLC owned 0.57% of Establishment Labs worth $7,371,000 as of its most recent SEC filing.

A number of other hedge funds have also modified their holdings of ESTA. Quarry LP acquired a new position in Establishment Labs during the 4th quarter worth about $27,000. R Squared Ltd acquired a new stake in Establishment Labs in the 4th quarter valued at about $36,000. Federated Hermes Inc. raised its position in Establishment Labs by 3.0% in the 4th quarter. Federated Hermes Inc. now owns 32,720 shares of the company's stock valued at $1,507,000 after purchasing an additional 953 shares in the last quarter. Swiss National Bank raised its position in Establishment Labs by 2.7% in the 4th quarter. Swiss National Bank now owns 38,500 shares of the company's stock valued at $1,774,000 after purchasing an additional 1,000 shares in the last quarter. Finally, Handelsbanken Fonder AB raised its position in Establishment Labs by 32.3% in the 4th quarter. Handelsbanken Fonder AB now owns 8,200 shares of the company's stock valued at $378,000 after purchasing an additional 2,000 shares in the last quarter. 72.91% of the stock is currently owned by hedge funds and other institutional investors.

Establishment Labs Trading Up 1.8%

Shares of ESTA stock opened at $36.82 on Tuesday. The business's 50 day moving average is $34.39 and its two-hundred day moving average is $38.12. Establishment Labs Holdings Inc. has a twelve month low of $26.56 and a twelve month high of $58.00. The company has a market capitalization of $1.06 billion, a P/E ratio of -14.27 and a beta of 0.73. The company has a current ratio of 3.62, a quick ratio of 2.29 and a debt-to-equity ratio of 5.94.

Establishment Labs (NASDAQ:ESTA - Get Free Report) last announced its earnings results on Wednesday, May 7th. The company reported ($0.70) earnings per share for the quarter, beating the consensus estimate of ($0.83) by $0.13. Establishment Labs had a negative return on equity of 184.55% and a negative net margin of 46.13%. The company had revenue of $41.38 million for the quarter, compared to the consensus estimate of $41.15 million. During the same period last year, the business posted ($0.58) EPS. The company's revenue was up 11.3% on a year-over-year basis. Equities analysts forecast that Establishment Labs Holdings Inc. will post -2.41 EPS for the current year.

Wall Street Analyst Weigh In

A number of equities research analysts have issued reports on ESTA shares. Stephens reaffirmed an "overweight" rating and issued a $52.00 price target on shares of Establishment Labs in a research report on Thursday, March 6th. Needham & Company LLC upgraded Establishment Labs from a "hold" rating to a "buy" rating and set a $48.00 price objective on the stock in a report on Wednesday, May 14th. Finally, BTIG Research started coverage on Establishment Labs in a report on Friday. They issued a "buy" rating and a $62.00 price objective on the stock. One investment analyst has rated the stock with a hold rating and five have assigned a buy rating to the company. According to MarketBeat.com, the stock presently has an average rating of "Moderate Buy" and an average price target of $55.33.

Establishment Labs Company Profile

Establishment Labs Holdings Inc, a medical technology company, manufactures and markets medical devices for aesthetic and reconstructive plastic surgery. The company primarily offers silicone gel-filled breast implants under the Motiva Implants brand. It also provides Motiva Ergonomix and Motiva Ergonomix2 gravity sensitive round soft silicone-gel-filled breast implants; and Motiva Flora Tissue Expander, a breast tissue expander.

Want to see what other hedge funds are holding ESTA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Establishment Labs Holdings Inc. (NASDAQ:ESTA - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.